Home > Boards > US Listed > Biotechs > Affimed Therapeutics (AFMD)

AFMD: new Corporate Presentation (May 7, 2019)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
TwoNE1 Member Profile
 
Followed By 0
Posts 95
Boards Moderated 0
Alias Born 01/27/11
160x600 placeholder
Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland GlobeNewswire Inc. - 6/12/2019 5:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2019 4:18:14 PM
Affimed Announces Annual General Meeting of Shareholders GlobeNewswire Inc. - 6/4/2019 4:01:00 PM
Icosagen and AbCheck Announce Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expres... GlobeNewswire Inc. - 6/3/2019 5:00:00 AM
Affimed to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire Inc. - 5/29/2019 5:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/22/2019 7:38:59 AM
Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operat... GlobeNewswire Inc. - 5/22/2019 7:30:00 AM
Affimed Announces First Quarter 2019 Financial Results and Corporate Update Conference Call on May 22, 2019 GlobeNewswire Inc. - 5/16/2019 5:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/17/2019 4:12:05 PM
Affimed Provides Regulatory Update on AFM11 Clinical Program GlobeNewswire Inc. - 4/17/2019 4:05:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/11/2019 4:36:18 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/9/2019 7:49:11 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/5/2019 4:10:39 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/2/2019 9:20:33 AM
Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Sol... GlobeNewswire Inc. - 4/1/2019 8:00:00 AM
Affimed Reports 2018 Financial Results and Operational Progress GlobeNewswire Inc. - 3/27/2019 7:30:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 3/27/2019 7:03:50 AM
Affimed Announces Full Year 2018 Financial Results Conference Call on March 27, 2019 GlobeNewswire Inc. - 3/20/2019 5:00:00 AM
Affimed Announces Milestone Payment from Genentech and ROCK® Platform Presentation at Innate Killer Summit 2019, Further Hig... GlobeNewswire Inc. - 3/19/2019 5:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 9:09:09 AM
Schedule 13g Edgar (US Regulatory) - 2/12/2019 9:38:48 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/25/2019 11:33:29 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/15/2019 4:34:47 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/7/2019 7:03:06 AM
Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City GlobeNewswire Inc. - 11/28/2018
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist